Works matching DE "THERAPEUTIC use of antineoplastic agents"
Results: 5000
Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae369
- By:
- Publication type:
- Article
Efficacy of cyclin-dependent kinase inhibitors with concurrent proton pump inhibitors in patients with breast cancer: a systematic review and meta-analysis.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae320
- By:
- Publication type:
- Article
Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae260
- By:
- Publication type:
- Article
The association of azole antifungals with overall survival in patients with non-small cell lung cancer receiving immune checkpoint inhibitors.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae262
- By:
- Publication type:
- Article
Conference Highlights. 25TH ANNUAL MEETING OF THE SOCIETY OF UROLOGIC ONCOLOGY.
- Published in:
- 2025
- By:
- Publication type:
- Abstract
Targeting HER2 in Gastroesophageal Cancer: A New Appetite for an Old Plight: Targeting HER2 in Gastroesophageal Cancer: A. Cammarota et al.
- Published in:
- Drugs, 2025, v. 85, n. 3, p. 361, doi. 10.1007/s40265-024-02132-2
- By:
- Publication type:
- Article
Patient Preferences for HR+/HER2− Early Breast Cancer Adjuvant Treatment: A Multicountry Discrete Choice Experiment.
- Published in:
- Breast Care, 2025, v. 20, n. 1, p. 16, doi. 10.1159/000543320
- By:
- Publication type:
- Article
Expert Discussion: ESMO 2024.
- Published in:
- 2025
- By:
- Publication type:
- Conference Paper/Materials
Utility of Assessing Early Tumor Shrinkage as an Efficacy Predictor in Patients with Non-Surgically Indicated or Recurrent Esophageal Cancer Treated with Nivolumab plus Ipilimumab.
- Published in:
- Oncology, 2025, v. 103, n. 3, p. 167, doi. 10.1159/000540851
- By:
- Publication type:
- Article
Pulmonary Adenocarcinoma with Enteric Differentiation without TTF-1 Expression Is a Very Rare Subtype with Limited Treatment Options and Poor Prognosis.
- Published in:
- Oncology, 2025, v. 103, n. 3, p. 179, doi. 10.1159/000540515
- By:
- Publication type:
- Article
Frankincense Oil: A Natural Remedy with Promising but Unproven Cancer Benefits.
- Published in:
- Indian Practitioner, 2025, v. 78, n. 2, p. 31
- Publication type:
- Article
3 Things You Should Know About Treating Epithelioid Sarcoma.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 88
- Publication type:
- Article
Sotorasib Combo Bests Chemo Leading to Approval in KRAS G12C+ CRC.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 85
- By:
- Publication type:
- Article
Overall survival with pembrolizumab in early-stage triple-negative breast cancer.
- Published in:
- Breast Cancer Research Review, 2025, n. 46, p. 5
- By:
- Publication type:
- Article
Essential barriers and considerations for the implementation of electronic patient-reported outcome (ePRO) measures in oncological practice: contextualizing the results of a feasibility study with existing literature.
- Published in:
- Journal of Public Health: From Theory to Practice (2198-1833), 2023, v. 31, n. 12, p. 2071, doi. 10.1007/s10389-022-01767-3
- By:
- Publication type:
- Article
Antitumor activity of gamma-irradiated Rosa canina L. against lung carcinoma in rat model: a proposed mechanism.
- Published in:
- BMC Complementary Medicine & Therapies, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12906-025-04813-1
- By:
- Publication type:
- Article
Enfortumab Vedotin Plus Pembrolizumab Compared to Pembrolizumab and Standard Chemotherapy: Birds of a Feather Flock Together in Urothelial Cancer.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Antifungal Prophylaxis in the Treatment Combination of Hypomethylating Agents and Venetoclax for AML: A Survey Study of the Turkish Society of Hematology Subcommittee on Infections and Supportive Therapies in Hematology.
- Published in:
- Turkish Journal of Hematology, 2025, v. 42, n. 1, p. 69, doi. 10.4274/tjh.galenos.2024.2024.0436
- By:
- Publication type:
- Article
Hypo-pigmented Lesions - Not as Innocuous as They Look.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Progress in Drug Delivery Systems Based on Nanoparticles for Improved Glioblastoma Therapy: Addressing Challenges and Investigating Opportunities.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 701, doi. 10.3390/cancers17040701
- By:
- Publication type:
- Article
Ancestry-Specific DNA Damage Repair Gene Mutations and Prostate Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 682, doi. 10.3390/cancers17040682
- By:
- Publication type:
- Article
Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16 , 2492
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Green Tea Components: In Vitro and In Vivo Evidence for Their Anticancer Potential in Colon Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 623, doi. 10.3390/cancers17040623
- By:
- Publication type:
- Article
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 598, doi. 10.3390/cancers17040598
- By:
- Publication type:
- Article
Epidemiology and Outcome of Primary Central Nervous System Tumors Treated at King Hussein Cancer Center.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 590, doi. 10.3390/cancers17040590
- By:
- Publication type:
- Article
Clinical and Molecular Predictors of Response and Survival Following Venetoclax Plus Hypomethylating Agents in Relapsed/Refractory Acute Myeloid Leukemia: A Single-Center Study in Chinese Patients.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 586, doi. 10.3390/cancers17040586
- By:
- Publication type:
- Article
Implications of Fumarate Hydratase Deficiency (FHD) and Cancer Risk: A Window into the Clinical and Oncological Implications of a Rare Disorder in Gynecology.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 573, doi. 10.3390/cancers17040573
- By:
- Publication type:
- Article
Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung Cancer.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 572, doi. 10.3390/cancers17040572
- By:
- Publication type:
- Article
Therapeutic Targeting of the Janus Kinase/Signal Transducer and Activator of Transcription Pathway in Cutaneous T-Cell Lymphoma.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 568, doi. 10.3390/cancers17040568
- By:
- Publication type:
- Article
Possibilities of Overcoming Resistance to Osimertinib in NSCLC Patients with Mutations in the EGFR Gene.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 563, doi. 10.3390/cancers17040563
- By:
- Publication type:
- Article
Omission of Axillary Surgery After Neoadjuvant Therapy in Her2-Positive Breast Cancer: Who Are the Candidates?
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 562, doi. 10.3390/cancers17040562
- By:
- Publication type:
- Article
Exploring the Potential of Adjuvant CDK4/6 Inhibitors in Hormone Receptor-Positive Early Breast Cancer: A Consistent Approach for All.
- Published in:
- Cancers, 2025, v. 17, n. 4, p. 561, doi. 10.3390/cancers17040561
- By:
- Publication type:
- Article
Advancements in the Research of Astragalus membranaceus for the Treatment of Colorectal Cancer.
- Published in:
- American Journal of Chinese Medicine, 2025, v. 53, n. 1, p. 119, doi. 10.1142/S0192415X25500065
- By:
- Publication type:
- Article
In Reply to Letter From Parkash and Smith.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2025, v. 149, n. 3, p. 208, doi. 10.5858/arpa.2024-0417-LE
- By:
- Publication type:
- Article
Development of an FRα Companion Diagnostic Immunohistochemical Assay for Mirvetuximab Soravtansine.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2025, v. 149, n. 3, p. 207, doi. 10.5858/arpa.2024-0277-LE
- By:
- Publication type:
- Article
Correction to: Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Nadofaragene firadenovec in high-risk Bacillus Calmette Guérin unresponsive non-muscle invasive bladder cancer: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 1, p. 1, doi. 10.1007/s40267-024-01045-0
- By:
- Publication type:
- Article
Preferably pre-empt pathological scars, or pick from a plethora of therapies.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 1, p. 22, doi. 10.1007/s40267-023-01040-x
- By:
- Publication type:
- Article
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 432, doi. 10.1007/s40267-023-01038-5
- By:
- Publication type:
- Article
The role of belzutifan, an inhibitor of hypoxia-inducible factor, for renal cell carcinoma in adults with Von Hippel–Lindau disease: a review.
- Published in:
- Drugs & Therapy Perspectives, 2023, v. 39, n. 11, p. 388, doi. 10.1007/s40267-023-01031-y
- By:
- Publication type:
- Article
Tisotumab vedotin-tftv in previously treated recurrent or metastatic cervical cancer: a profile of its use in the USA.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 9, p. 382, doi. 10.1007/s40267-022-00939-1
- By:
- Publication type:
- Article
Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma: a profile of its use in the USA.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 6, p. 261, doi. 10.1007/s40267-022-00922-w
- By:
- Publication type:
- Article
Targeted therapy for metastatic colorectal cancer: what do we currently have in clinical practice?
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 5, p. 222, doi. 10.1007/s40267-022-00915-9
- By:
- Publication type:
- Article
Initiation of Oral Endocrine Therapy and Survival Benefit Among Women with Early-Stage Breast Cancer.
- Published in:
- Journal of Women's Health (15409996), 2024, v. 33, n. 11, p. 1509, doi. 10.1089/jwh.2023.0971
- By:
- Publication type:
- Article
Progressive hypertrophic genital herpes in an HIV-infected woman despite immune recovery on antiretroviral therapy.
- Published in:
- 2008
- By:
- Publication type:
- journal article
In silico Study of Chromane Ring Compound Rubranonoside from Plumeria rubra as Anticancer Potential.
- Published in:
- Trends in Sciences, 2022, v. 19, n. 24, p. 1, doi. 10.48048/tis.2022.3305
- By:
- Publication type:
- Article
Management of Hepatitis B Virus Infection and Prevention of Hepatitis B Virus Reactivation in Children With Acquired Immunodeficiencies or Undergoing Immune Suppressive, Cytotoxic, or Biological Modifier Therapies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Anticancer Effects of Punicalagin.
- Published in:
- Haydarpasa Numune Medical Journal, 2023, v. 63, n. 1, p. 99, doi. 10.14744/hnhj.2021.77044
- By:
- Publication type:
- Article
Effect of Maintenance anti-EGFR Therapy on Survival in Metastatic RAS Wild-Type Colorectal Cancer: Single-Center Experience.
- Published in:
- Eurasian Journal of Medical Investigation, 2024, v. 8, n. 4, p. 280, doi. 10.14744/ejmi.2024.53878
- By:
- Publication type:
- Article
Prognostic Factors in Extensive-Stage Small Cell Lung Cancer: An Evaluation of LIPI, mGPS, and PIV Scores.
- Published in:
- Eurasian Journal of Medical Investigation, 2024, v. 8, n. 4, p. 260, doi. 10.14744/ejmi.2024.38549
- By:
- Publication type:
- Article